Adial Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Adial Pharmaceuticals, Inc.

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is…

Biotechnology
US, Charlottesville [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of ADIL's Analysis
CIK: 1513525 CUSIP: 00688A106 ISIN: US00688A2050 LEI: - UEI: -
Secondary Listings
ADIL has no secondary listings inside our databases.